販売および管理費 変化する 日付
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amgen USD 1.7B 9M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Cytokinetics USD 158.75M 93.03M 2025-09
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Gilead Sciences USD 1.35B 6M 2025-09
Incyte USD 329.08M 1.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Novartis USD 3.31B 134M 2025-09
Pfizer USD 3.19B 209M 2025-09
PTC Therapeutics USD 84.05M 1.22M 2025-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
TG Therapeutics USD 63.37M 51.33M 2025-09
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09
Xencor USD 87.78M 72.66M 2025-09


PTC Therapeutics 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.